nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—CYP2B6—Thiotepa—urinary bladder cancer	0.0974	0.141	CbGbCtD
Nelfinavir—ABCB1—Mitomycin—urinary bladder cancer	0.0659	0.0954	CbGbCtD
Nelfinavir—ABCG2—Fluorouracil—urinary bladder cancer	0.045	0.0651	CbGbCtD
Nelfinavir—ABCG2—Carboplatin—urinary bladder cancer	0.0447	0.0647	CbGbCtD
Nelfinavir—ABCG2—Cisplatin—urinary bladder cancer	0.0382	0.0553	CbGbCtD
Nelfinavir—ABCG2—Etoposide—urinary bladder cancer	0.0376	0.0544	CbGbCtD
Nelfinavir—SLCO1A2—Methotrexate—urinary bladder cancer	0.0331	0.0479	CbGbCtD
Nelfinavir—SLCO1B1—Methotrexate—urinary bladder cancer	0.0312	0.0452	CbGbCtD
Nelfinavir—CYP3A4—Thiotepa—urinary bladder cancer	0.0299	0.0433	CbGbCtD
Nelfinavir—CYP2B6—Cisplatin—urinary bladder cancer	0.0269	0.0389	CbGbCtD
Nelfinavir—ABCG2—Doxorubicin—urinary bladder cancer	0.0256	0.0371	CbGbCtD
Nelfinavir—ABCG2—Methotrexate—urinary bladder cancer	0.0248	0.0359	CbGbCtD
Nelfinavir—CYP3A5—Etoposide—urinary bladder cancer	0.0208	0.0301	CbGbCtD
Nelfinavir—ABCB1—Gemcitabine—urinary bladder cancer	0.019	0.0275	CbGbCtD
Nelfinavir—CYP1A2—Fluorouracil—urinary bladder cancer	0.0186	0.0269	CbGbCtD
Nelfinavir—CYP2B6—Doxorubicin—urinary bladder cancer	0.018	0.0261	CbGbCtD
Nelfinavir—CYP2C9—Fluorouracil—urinary bladder cancer	0.0167	0.0242	CbGbCtD
Nelfinavir—CYP1A2—Etoposide—urinary bladder cancer	0.0155	0.0224	CbGbCtD
Nelfinavir—CYP2C9—Cisplatin—urinary bladder cancer	0.0142	0.0206	CbGbCtD
Nelfinavir—ABCB1—Cisplatin—urinary bladder cancer	0.0138	0.0199	CbGbCtD
Nelfinavir—ABCB1—Etoposide—urinary bladder cancer	0.0135	0.0196	CbGbCtD
Nelfinavir—ABCB1—Doxorubicin—urinary bladder cancer	0.00924	0.0134	CbGbCtD
Nelfinavir—ABCB1—Methotrexate—urinary bladder cancer	0.00895	0.0129	CbGbCtD
Nelfinavir—CYP2D6—Doxorubicin—urinary bladder cancer	0.0087	0.0126	CbGbCtD
Nelfinavir—CYP3A4—Etoposide—urinary bladder cancer	0.00811	0.0117	CbGbCtD
Nelfinavir—CYP3A4—Doxorubicin—urinary bladder cancer	0.00553	0.00801	CbGbCtD
Nelfinavir—Mitiglinide—UGT2B7—urinary bladder cancer	0.00485	0.719	CrCbGaD
Nelfinavir—CYP2C19—urine—urinary bladder cancer	0.00298	0.108	CbGeAlD
Nelfinavir—CYP1A2—urine—urinary bladder cancer	0.00243	0.0883	CbGeAlD
Nelfinavir—CYP2C9—urine—urinary bladder cancer	0.00231	0.0838	CbGeAlD
Nelfinavir—Mitiglinide—PPARG—urinary bladder cancer	0.00189	0.281	CrCbGaD
Nelfinavir—CYP3A4—urine—urinary bladder cancer	0.00176	0.0639	CbGeAlD
Nelfinavir—CYP2D6—urine—urinary bladder cancer	0.00173	0.0629	CbGeAlD
Nelfinavir—SLCO1B1—renal system—urinary bladder cancer	0.00112	0.0406	CbGeAlD
Nelfinavir—SLC22A1—renal system—urinary bladder cancer	0.000946	0.0343	CbGeAlD
Nelfinavir—SLCO1A2—renal system—urinary bladder cancer	0.000911	0.0331	CbGeAlD
Nelfinavir—ABCG2—prostate gland—urinary bladder cancer	0.000908	0.0329	CbGeAlD
Nelfinavir—SLCO1B1—female reproductive system—urinary bladder cancer	0.000896	0.0325	CbGeAlD
Nelfinavir—CYP3A5—prostate gland—urinary bladder cancer	0.000843	0.0306	CbGeAlD
Nelfinavir—ABCG2—seminal vesicle—urinary bladder cancer	0.000768	0.0279	CbGeAlD
Nelfinavir—SLC22A1—vagina—urinary bladder cancer	0.000685	0.0249	CbGeAlD
Nelfinavir—ABCG2—urethra—urinary bladder cancer	0.000608	0.0221	CbGeAlD
Nelfinavir—CYP1A2—renal system—urinary bladder cancer	0.000596	0.0216	CbGeAlD
Nelfinavir—CYP3A5—renal system—urinary bladder cancer	0.000574	0.0208	CbGeAlD
Nelfinavir—CYP2B6—renal system—urinary bladder cancer	0.000571	0.0207	CbGeAlD
Nelfinavir—CYP2C19—vagina—urinary bladder cancer	0.000528	0.0192	CbGeAlD
Nelfinavir—CYP2B6—female reproductive system—urinary bladder cancer	0.000457	0.0166	CbGeAlD
Nelfinavir—CYP2C9—female reproductive system—urinary bladder cancer	0.000453	0.0164	CbGeAlD
Nelfinavir—ABCG2—vagina—urinary bladder cancer	0.000448	0.0163	CbGeAlD
Nelfinavir—ABCB1—prostate gland—urinary bladder cancer	0.000448	0.0162	CbGeAlD
Nelfinavir—CYP3A4—renal system—urinary bladder cancer	0.000431	0.0156	CbGeAlD
Nelfinavir—CYP2D6—renal system—urinary bladder cancer	0.000424	0.0154	CbGeAlD
Nelfinavir—CYP3A5—vagina—urinary bladder cancer	0.000416	0.0151	CbGeAlD
Nelfinavir—CYP2B6—vagina—urinary bladder cancer	0.000414	0.015	CbGeAlD
Nelfinavir—ABCB1—seminal vesicle—urinary bladder cancer	0.000379	0.0137	CbGeAlD
Nelfinavir—CYP3A4—female reproductive system—urinary bladder cancer	0.000345	0.0125	CbGeAlD
Nelfinavir—CYP2D6—female reproductive system—urinary bladder cancer	0.00034	0.0123	CbGeAlD
Nelfinavir—ABCB1—epithelium—urinary bladder cancer	0.000329	0.0119	CbGeAlD
Nelfinavir—ABCB1—renal system—urinary bladder cancer	0.000305	0.0111	CbGeAlD
Nelfinavir—ABCB1—urethra—urinary bladder cancer	0.0003	0.0109	CbGeAlD
Nelfinavir—ABCG2—lymph node—urinary bladder cancer	0.00029	0.0105	CbGeAlD
Nelfinavir—ABCB1—female reproductive system—urinary bladder cancer	0.000244	0.00887	CbGeAlD
Nelfinavir—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000228	0.00128	CcSEcCtD
Nelfinavir—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000228	0.00128	CcSEcCtD
Nelfinavir—Anorexia—Etoposide—urinary bladder cancer	0.000225	0.00126	CcSEcCtD
Nelfinavir—Diarrhoea—Thiotepa—urinary bladder cancer	0.000225	0.00126	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000225	0.00126	CcSEcCtD
Nelfinavir—Decreased appetite—Cisplatin—urinary bladder cancer	0.000224	0.00126	CcSEcCtD
Nelfinavir—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000224	0.00126	CcSEcCtD
Nelfinavir—Pneumonia—Methotrexate—urinary bladder cancer	0.000223	0.00125	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000223	0.00125	CcSEcCtD
Nelfinavir—ABCB1—vagina—urinary bladder cancer	0.000221	0.00802	CbGeAlD
Nelfinavir—Pain—Cisplatin—urinary bladder cancer	0.000221	0.00124	CcSEcCtD
Nelfinavir—Muscular weakness—Doxorubicin—urinary bladder cancer	0.00022	0.00123	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.00022	0.00123	CcSEcCtD
Nelfinavir—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000219	0.00123	CcSEcCtD
Nelfinavir—Neutropenia—Epirubicin—urinary bladder cancer	0.000218	0.00122	CcSEcCtD
Nelfinavir—Dizziness—Thiotepa—urinary bladder cancer	0.000218	0.00122	CcSEcCtD
Nelfinavir—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000217	0.00122	CcSEcCtD
Nelfinavir—Stomatitis—Methotrexate—urinary bladder cancer	0.000216	0.00121	CcSEcCtD
Nelfinavir—Urticaria—Fluorouracil—urinary bladder cancer	0.000216	0.00121	CcSEcCtD
Nelfinavir—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000215	0.0012	CcSEcCtD
Nelfinavir—Sweating—Methotrexate—urinary bladder cancer	0.000213	0.00119	CcSEcCtD
Nelfinavir—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000213	0.00119	CcSEcCtD
Nelfinavir—Paraesthesia—Etoposide—urinary bladder cancer	0.000212	0.00119	CcSEcCtD
Nelfinavir—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000211	0.00118	CcSEcCtD
Nelfinavir—Dyspnoea—Etoposide—urinary bladder cancer	0.000211	0.00118	CcSEcCtD
Nelfinavir—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.00021	0.00118	CcSEcCtD
Nelfinavir—Somnolence—Etoposide—urinary bladder cancer	0.00021	0.00118	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.00021	0.00118	CcSEcCtD
Nelfinavir—Epistaxis—Methotrexate—urinary bladder cancer	0.000209	0.00117	CcSEcCtD
Nelfinavir—Vomiting—Thiotepa—urinary bladder cancer	0.000209	0.00117	CcSEcCtD
Nelfinavir—Pneumonia—Epirubicin—urinary bladder cancer	0.000209	0.00117	CcSEcCtD
Nelfinavir—Rash—Thiotepa—urinary bladder cancer	0.000207	0.00116	CcSEcCtD
Nelfinavir—Dermatitis—Thiotepa—urinary bladder cancer	0.000207	0.00116	CcSEcCtD
Nelfinavir—Headache—Thiotepa—urinary bladder cancer	0.000206	0.00115	CcSEcCtD
Nelfinavir—Decreased appetite—Etoposide—urinary bladder cancer	0.000205	0.00115	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000204	0.00114	CcSEcCtD
Nelfinavir—Body temperature increased—Cisplatin—urinary bladder cancer	0.000204	0.00114	CcSEcCtD
Nelfinavir—Jaundice—Epirubicin—urinary bladder cancer	0.000202	0.00113	CcSEcCtD
Nelfinavir—Stomatitis—Epirubicin—urinary bladder cancer	0.000202	0.00113	CcSEcCtD
Nelfinavir—Pain—Etoposide—urinary bladder cancer	0.000202	0.00113	CcSEcCtD
Nelfinavir—Neutropenia—Doxorubicin—urinary bladder cancer	0.000202	0.00113	CcSEcCtD
Nelfinavir—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.0002	0.00112	CcSEcCtD
Nelfinavir—Haemoglobin—Methotrexate—urinary bladder cancer	0.0002	0.00112	CcSEcCtD
Nelfinavir—Haemorrhage—Methotrexate—urinary bladder cancer	0.000199	0.00112	CcSEcCtD
Nelfinavir—Hepatitis—Methotrexate—urinary bladder cancer	0.000199	0.00112	CcSEcCtD
Nelfinavir—Sweating—Epirubicin—urinary bladder cancer	0.000199	0.00112	CcSEcCtD
Nelfinavir—Asthenia—Gemcitabine—urinary bladder cancer	0.000199	0.00111	CcSEcCtD
Nelfinavir—Pharyngitis—Methotrexate—urinary bladder cancer	0.000198	0.00111	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000196	0.0011	CcSEcCtD
Nelfinavir—Epistaxis—Epirubicin—urinary bladder cancer	0.000196	0.0011	CcSEcCtD
Nelfinavir—Pruritus—Gemcitabine—urinary bladder cancer	0.000196	0.0011	CcSEcCtD
Nelfinavir—Nausea—Thiotepa—urinary bladder cancer	0.000195	0.00109	CcSEcCtD
Nelfinavir—Sinusitis—Epirubicin—urinary bladder cancer	0.000195	0.00109	CcSEcCtD
Nelfinavir—Feeling abnormal—Etoposide—urinary bladder cancer	0.000195	0.00109	CcSEcCtD
Nelfinavir—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000194	0.00109	CcSEcCtD
Nelfinavir—Pneumonia—Doxorubicin—urinary bladder cancer	0.000193	0.00108	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000193	0.00108	CcSEcCtD
Nelfinavir—Pruritus—Fluorouracil—urinary bladder cancer	0.000193	0.00108	CcSEcCtD
Nelfinavir—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00019	0.00106	CcSEcCtD
Nelfinavir—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000189	0.00106	CcSEcCtD
Nelfinavir—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000188	0.00106	CcSEcCtD
Nelfinavir—Urticaria—Etoposide—urinary bladder cancer	0.000188	0.00105	CcSEcCtD
Nelfinavir—Haemoglobin—Epirubicin—urinary bladder cancer	0.000187	0.00105	CcSEcCtD
Nelfinavir—Stomatitis—Doxorubicin—urinary bladder cancer	0.000187	0.00105	CcSEcCtD
Nelfinavir—Jaundice—Doxorubicin—urinary bladder cancer	0.000187	0.00105	CcSEcCtD
Nelfinavir—Rhinitis—Epirubicin—urinary bladder cancer	0.000187	0.00105	CcSEcCtD
Nelfinavir—Abdominal pain—Etoposide—urinary bladder cancer	0.000187	0.00105	CcSEcCtD
Nelfinavir—Body temperature increased—Etoposide—urinary bladder cancer	0.000187	0.00105	CcSEcCtD
Nelfinavir—Haemorrhage—Epirubicin—urinary bladder cancer	0.000186	0.00104	CcSEcCtD
Nelfinavir—Hepatitis—Epirubicin—urinary bladder cancer	0.000186	0.00104	CcSEcCtD
Nelfinavir—Eye disorder—Methotrexate—urinary bladder cancer	0.000186	0.00104	CcSEcCtD
Nelfinavir—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000186	0.00104	CcSEcCtD
Nelfinavir—Asthenia—Cisplatin—urinary bladder cancer	0.000185	0.00104	CcSEcCtD
Nelfinavir—Pharyngitis—Epirubicin—urinary bladder cancer	0.000185	0.00104	CcSEcCtD
Nelfinavir—Sweating—Doxorubicin—urinary bladder cancer	0.000184	0.00103	CcSEcCtD
Nelfinavir—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000183	0.00103	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000182	0.00102	CcSEcCtD
Nelfinavir—Epistaxis—Doxorubicin—urinary bladder cancer	0.000181	0.00102	CcSEcCtD
Nelfinavir—Angiopathy—Methotrexate—urinary bladder cancer	0.000181	0.00101	CcSEcCtD
Nelfinavir—Sinusitis—Doxorubicin—urinary bladder cancer	0.00018	0.00101	CcSEcCtD
Nelfinavir—Immune system disorder—Methotrexate—urinary bladder cancer	0.00018	0.00101	CcSEcCtD
Nelfinavir—Dizziness—Fluorouracil—urinary bladder cancer	0.00018	0.00101	CcSEcCtD
Nelfinavir—Diarrhoea—Cisplatin—urinary bladder cancer	0.000176	0.000988	CcSEcCtD
Nelfinavir—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000176	0.000987	CcSEcCtD
Nelfinavir—Vomiting—Gemcitabine—urinary bladder cancer	0.000176	0.000986	CcSEcCtD
Nelfinavir—Rash—Gemcitabine—urinary bladder cancer	0.000174	0.000977	CcSEcCtD
Nelfinavir—Dermatitis—Gemcitabine—urinary bladder cancer	0.000174	0.000976	CcSEcCtD
Nelfinavir—Eye disorder—Epirubicin—urinary bladder cancer	0.000174	0.000976	CcSEcCtD
Nelfinavir—Hypersensitivity—Etoposide—urinary bladder cancer	0.000174	0.000975	CcSEcCtD
Nelfinavir—Malnutrition—Methotrexate—urinary bladder cancer	0.000173	0.000971	CcSEcCtD
Nelfinavir—Erythema—Methotrexate—urinary bladder cancer	0.000173	0.000971	CcSEcCtD
Nelfinavir—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000173	0.000971	CcSEcCtD
Nelfinavir—Headache—Gemcitabine—urinary bladder cancer	0.000173	0.000971	CcSEcCtD
Nelfinavir—Vomiting—Fluorouracil—urinary bladder cancer	0.000173	0.000969	CcSEcCtD
Nelfinavir—Rhinitis—Doxorubicin—urinary bladder cancer	0.000173	0.000969	CcSEcCtD
Nelfinavir—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000173	0.000966	CcSEcCtD
Nelfinavir—Hepatitis—Doxorubicin—urinary bladder cancer	0.000173	0.000966	CcSEcCtD
Nelfinavir—Rash—Fluorouracil—urinary bladder cancer	0.000172	0.000961	CcSEcCtD
Nelfinavir—Dermatitis—Fluorouracil—urinary bladder cancer	0.000171	0.00096	CcSEcCtD
Nelfinavir—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000171	0.000959	CcSEcCtD
Nelfinavir—Headache—Fluorouracil—urinary bladder cancer	0.00017	0.000955	CcSEcCtD
Nelfinavir—Asthenia—Etoposide—urinary bladder cancer	0.00017	0.00095	CcSEcCtD
Nelfinavir—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.00017	0.00095	CcSEcCtD
Nelfinavir—Angiopathy—Epirubicin—urinary bladder cancer	0.000169	0.000947	CcSEcCtD
Nelfinavir—Immune system disorder—Epirubicin—urinary bladder cancer	0.000168	0.000943	CcSEcCtD
Nelfinavir—Back pain—Methotrexate—urinary bladder cancer	0.000168	0.00094	CcSEcCtD
Nelfinavir—Pruritus—Etoposide—urinary bladder cancer	0.000167	0.000936	CcSEcCtD
Nelfinavir—Nausea—Gemcitabine—urinary bladder cancer	0.000164	0.000921	CcSEcCtD
Nelfinavir—Vomiting—Cisplatin—urinary bladder cancer	0.000164	0.000919	CcSEcCtD
Nelfinavir—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000163	0.000914	CcSEcCtD
Nelfinavir—Rash—Cisplatin—urinary bladder cancer	0.000163	0.000911	CcSEcCtD
Nelfinavir—Dermatitis—Cisplatin—urinary bladder cancer	0.000162	0.00091	CcSEcCtD
Nelfinavir—Erythema—Epirubicin—urinary bladder cancer	0.000162	0.000909	CcSEcCtD
Nelfinavir—Malnutrition—Epirubicin—urinary bladder cancer	0.000162	0.000909	CcSEcCtD
Nelfinavir—Diarrhoea—Etoposide—urinary bladder cancer	0.000162	0.000906	CcSEcCtD
Nelfinavir—Nausea—Fluorouracil—urinary bladder cancer	0.000162	0.000905	CcSEcCtD
Nelfinavir—Eye disorder—Doxorubicin—urinary bladder cancer	0.000161	0.000903	CcSEcCtD
Nelfinavir—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000161	0.000901	CcSEcCtD
Nelfinavir—Anaemia—Methotrexate—urinary bladder cancer	0.00016	0.000898	CcSEcCtD
Nelfinavir—Flatulence—Epirubicin—urinary bladder cancer	0.00016	0.000896	CcSEcCtD
Nelfinavir—Back pain—Epirubicin—urinary bladder cancer	0.000157	0.000879	CcSEcCtD
Nelfinavir—Angiopathy—Doxorubicin—urinary bladder cancer	0.000157	0.000877	CcSEcCtD
Nelfinavir—Malaise—Methotrexate—urinary bladder cancer	0.000156	0.000876	CcSEcCtD
Nelfinavir—Dizziness—Etoposide—urinary bladder cancer	0.000156	0.000875	CcSEcCtD
Nelfinavir—Muscle spasms—Epirubicin—urinary bladder cancer	0.000156	0.000874	CcSEcCtD
Nelfinavir—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000156	0.000873	CcSEcCtD
Nelfinavir—Leukopenia—Methotrexate—urinary bladder cancer	0.000155	0.00087	CcSEcCtD
Nelfinavir—Nausea—Cisplatin—urinary bladder cancer	0.000153	0.000858	CcSEcCtD
Nelfinavir—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000151	0.000843	CcSEcCtD
Nelfinavir—Convulsion—Methotrexate—urinary bladder cancer	0.00015	0.000842	CcSEcCtD
Nelfinavir—Vomiting—Etoposide—urinary bladder cancer	0.00015	0.000842	CcSEcCtD
Nelfinavir—Malnutrition—Doxorubicin—urinary bladder cancer	0.00015	0.000841	CcSEcCtD
Nelfinavir—Erythema—Doxorubicin—urinary bladder cancer	0.00015	0.000841	CcSEcCtD
Nelfinavir—Anaemia—Epirubicin—urinary bladder cancer	0.00015	0.00084	CcSEcCtD
Nelfinavir—Agitation—Epirubicin—urinary bladder cancer	0.000149	0.000835	CcSEcCtD
Nelfinavir—Rash—Etoposide—urinary bladder cancer	0.000149	0.000835	CcSEcCtD
Nelfinavir—Dermatitis—Etoposide—urinary bladder cancer	0.000149	0.000834	CcSEcCtD
Nelfinavir—Headache—Etoposide—urinary bladder cancer	0.000148	0.000829	CcSEcCtD
Nelfinavir—Flatulence—Doxorubicin—urinary bladder cancer	0.000148	0.000829	CcSEcCtD
Nelfinavir—Arthralgia—Methotrexate—urinary bladder cancer	0.000148	0.000827	CcSEcCtD
Nelfinavir—Myalgia—Methotrexate—urinary bladder cancer	0.000148	0.000827	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000147	0.000821	CcSEcCtD
Nelfinavir—Malaise—Epirubicin—urinary bladder cancer	0.000146	0.00082	CcSEcCtD
Nelfinavir—Discomfort—Methotrexate—urinary bladder cancer	0.000146	0.000817	CcSEcCtD
Nelfinavir—Leukopenia—Epirubicin—urinary bladder cancer	0.000145	0.000814	CcSEcCtD
Nelfinavir—Back pain—Doxorubicin—urinary bladder cancer	0.000145	0.000814	CcSEcCtD
Nelfinavir—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000144	0.000809	CcSEcCtD
Nelfinavir—ABCB1—lymph node—urinary bladder cancer	0.000143	0.00519	CbGeAlD
Nelfinavir—Convulsion—Epirubicin—urinary bladder cancer	0.000141	0.000788	CcSEcCtD
Nelfinavir—Nausea—Etoposide—urinary bladder cancer	0.00014	0.000786	CcSEcCtD
Nelfinavir—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000139	0.00078	CcSEcCtD
Nelfinavir—Anaemia—Doxorubicin—urinary bladder cancer	0.000139	0.000777	CcSEcCtD
Nelfinavir—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000139	0.000776	CcSEcCtD
Nelfinavir—Arthralgia—Epirubicin—urinary bladder cancer	0.000138	0.000774	CcSEcCtD
Nelfinavir—Myalgia—Epirubicin—urinary bladder cancer	0.000138	0.000774	CcSEcCtD
Nelfinavir—Agitation—Doxorubicin—urinary bladder cancer	0.000138	0.000773	CcSEcCtD
Nelfinavir—Anxiety—Epirubicin—urinary bladder cancer	0.000138	0.000771	CcSEcCtD
Nelfinavir—Skin disorder—Methotrexate—urinary bladder cancer	0.000137	0.00077	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000137	0.000769	CcSEcCtD
Nelfinavir—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000137	0.000766	CcSEcCtD
Nelfinavir—Discomfort—Epirubicin—urinary bladder cancer	0.000137	0.000765	CcSEcCtD
Nelfinavir—Malaise—Doxorubicin—urinary bladder cancer	0.000135	0.000759	CcSEcCtD
Nelfinavir—Anorexia—Methotrexate—urinary bladder cancer	0.000135	0.000756	CcSEcCtD
Nelfinavir—Leukopenia—Doxorubicin—urinary bladder cancer	0.000134	0.000753	CcSEcCtD
Nelfinavir—Oedema—Epirubicin—urinary bladder cancer	0.000132	0.000742	CcSEcCtD
Nelfinavir—Convulsion—Doxorubicin—urinary bladder cancer	0.00013	0.000729	CcSEcCtD
Nelfinavir—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00013	0.000726	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000129	0.000722	CcSEcCtD
Nelfinavir—Skin disorder—Epirubicin—urinary bladder cancer	0.000129	0.000721	CcSEcCtD
Nelfinavir—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000128	0.000717	CcSEcCtD
Nelfinavir—Insomnia—Methotrexate—urinary bladder cancer	0.000128	0.000717	CcSEcCtD
Nelfinavir—Arthralgia—Doxorubicin—urinary bladder cancer	0.000128	0.000716	CcSEcCtD
Nelfinavir—Myalgia—Doxorubicin—urinary bladder cancer	0.000128	0.000716	CcSEcCtD
Nelfinavir—Anxiety—Doxorubicin—urinary bladder cancer	0.000127	0.000714	CcSEcCtD
Nelfinavir—Paraesthesia—Methotrexate—urinary bladder cancer	0.000127	0.000712	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000127	0.000711	CcSEcCtD
Nelfinavir—Discomfort—Doxorubicin—urinary bladder cancer	0.000126	0.000708	CcSEcCtD
Nelfinavir—Anorexia—Epirubicin—urinary bladder cancer	0.000126	0.000707	CcSEcCtD
Nelfinavir—Dyspnoea—Methotrexate—urinary bladder cancer	0.000126	0.000707	CcSEcCtD
Nelfinavir—Somnolence—Methotrexate—urinary bladder cancer	0.000126	0.000705	CcSEcCtD
Nelfinavir—Dyspepsia—Methotrexate—urinary bladder cancer	0.000125	0.000698	CcSEcCtD
Nelfinavir—Decreased appetite—Methotrexate—urinary bladder cancer	0.000123	0.000689	CcSEcCtD
Nelfinavir—Oedema—Doxorubicin—urinary bladder cancer	0.000123	0.000686	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000122	0.000684	CcSEcCtD
Nelfinavir—Pain—Methotrexate—urinary bladder cancer	0.000121	0.000678	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000121	0.000676	CcSEcCtD
Nelfinavir—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.00012	0.000672	CcSEcCtD
Nelfinavir—Insomnia—Epirubicin—urinary bladder cancer	0.00012	0.000671	CcSEcCtD
Nelfinavir—Skin disorder—Doxorubicin—urinary bladder cancer	0.000119	0.000667	CcSEcCtD
Nelfinavir—Paraesthesia—Epirubicin—urinary bladder cancer	0.000119	0.000666	CcSEcCtD
Nelfinavir—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000118	0.000664	CcSEcCtD
Nelfinavir—Dyspnoea—Epirubicin—urinary bladder cancer	0.000118	0.000661	CcSEcCtD
Nelfinavir—Somnolence—Epirubicin—urinary bladder cancer	0.000118	0.00066	CcSEcCtD
Nelfinavir—Anorexia—Doxorubicin—urinary bladder cancer	0.000117	0.000654	CcSEcCtD
Nelfinavir—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000117	0.000653	CcSEcCtD
Nelfinavir—Dyspepsia—Epirubicin—urinary bladder cancer	0.000117	0.000653	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000116	0.000648	CcSEcCtD
Nelfinavir—Decreased appetite—Epirubicin—urinary bladder cancer	0.000115	0.000645	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000114	0.000641	CcSEcCtD
Nelfinavir—Pain—Epirubicin—urinary bladder cancer	0.000113	0.000634	CcSEcCtD
Nelfinavir—Urticaria—Methotrexate—urinary bladder cancer	0.000112	0.00063	CcSEcCtD
Nelfinavir—Abdominal pain—Methotrexate—urinary bladder cancer	0.000112	0.000627	CcSEcCtD
Nelfinavir—Body temperature increased—Methotrexate—urinary bladder cancer	0.000112	0.000627	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000112	0.000625	CcSEcCtD
Nelfinavir—Insomnia—Doxorubicin—urinary bladder cancer	0.000111	0.000621	CcSEcCtD
Nelfinavir—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00011	0.000616	CcSEcCtD
Nelfinavir—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000109	0.000612	CcSEcCtD
Nelfinavir—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000109	0.000611	CcSEcCtD
Nelfinavir—Somnolence—Doxorubicin—urinary bladder cancer	0.000109	0.00061	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000108	0.000607	CcSEcCtD
Nelfinavir—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000108	0.000604	CcSEcCtD
Nelfinavir—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000107	0.000597	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000106	0.000593	CcSEcCtD
Nelfinavir—Urticaria—Epirubicin—urinary bladder cancer	0.000105	0.000589	CcSEcCtD
Nelfinavir—Pain—Doxorubicin—urinary bladder cancer	0.000105	0.000587	CcSEcCtD
Nelfinavir—Abdominal pain—Epirubicin—urinary bladder cancer	0.000105	0.000586	CcSEcCtD
Nelfinavir—Body temperature increased—Epirubicin—urinary bladder cancer	0.000105	0.000586	CcSEcCtD
Nelfinavir—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000104	0.000584	CcSEcCtD
Nelfinavir—Asthenia—Methotrexate—urinary bladder cancer	0.000102	0.000569	CcSEcCtD
Nelfinavir—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000101	0.000566	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.0001	0.000561	CcSEcCtD
Nelfinavir—Pruritus—Methotrexate—urinary bladder cancer	0.0001	0.000561	CcSEcCtD
Nelfinavir—Hypersensitivity—Epirubicin—urinary bladder cancer	9.76e-05	0.000547	CcSEcCtD
Nelfinavir—Urticaria—Doxorubicin—urinary bladder cancer	9.74e-05	0.000545	CcSEcCtD
Nelfinavir—Abdominal pain—Doxorubicin—urinary bladder cancer	9.69e-05	0.000543	CcSEcCtD
Nelfinavir—Body temperature increased—Doxorubicin—urinary bladder cancer	9.69e-05	0.000543	CcSEcCtD
Nelfinavir—Diarrhoea—Methotrexate—urinary bladder cancer	9.68e-05	0.000542	CcSEcCtD
Nelfinavir—Asthenia—Epirubicin—urinary bladder cancer	9.5e-05	0.000532	CcSEcCtD
Nelfinavir—Pruritus—Epirubicin—urinary bladder cancer	9.37e-05	0.000525	CcSEcCtD
Nelfinavir—Dizziness—Methotrexate—urinary bladder cancer	9.36e-05	0.000524	CcSEcCtD
Nelfinavir—Diarrhoea—Epirubicin—urinary bladder cancer	9.06e-05	0.000508	CcSEcCtD
Nelfinavir—Hypersensitivity—Doxorubicin—urinary bladder cancer	9.03e-05	0.000506	CcSEcCtD
Nelfinavir—Vomiting—Methotrexate—urinary bladder cancer	9e-05	0.000504	CcSEcCtD
Nelfinavir—Rash—Methotrexate—urinary bladder cancer	8.92e-05	0.0005	CcSEcCtD
Nelfinavir—Dermatitis—Methotrexate—urinary bladder cancer	8.92e-05	0.000499	CcSEcCtD
Nelfinavir—Headache—Methotrexate—urinary bladder cancer	8.87e-05	0.000497	CcSEcCtD
Nelfinavir—Asthenia—Doxorubicin—urinary bladder cancer	8.79e-05	0.000493	CcSEcCtD
Nelfinavir—Dizziness—Epirubicin—urinary bladder cancer	8.76e-05	0.000491	CcSEcCtD
Nelfinavir—Pruritus—Doxorubicin—urinary bladder cancer	8.67e-05	0.000486	CcSEcCtD
Nelfinavir—Vomiting—Epirubicin—urinary bladder cancer	8.42e-05	0.000472	CcSEcCtD
Nelfinavir—Nausea—Methotrexate—urinary bladder cancer	8.41e-05	0.000471	CcSEcCtD
Nelfinavir—Diarrhoea—Doxorubicin—urinary bladder cancer	8.39e-05	0.00047	CcSEcCtD
Nelfinavir—Rash—Epirubicin—urinary bladder cancer	8.35e-05	0.000468	CcSEcCtD
Nelfinavir—Dermatitis—Epirubicin—urinary bladder cancer	8.34e-05	0.000467	CcSEcCtD
Nelfinavir—Headache—Epirubicin—urinary bladder cancer	8.3e-05	0.000465	CcSEcCtD
Nelfinavir—Dizziness—Doxorubicin—urinary bladder cancer	8.11e-05	0.000454	CcSEcCtD
Nelfinavir—Nausea—Epirubicin—urinary bladder cancer	7.87e-05	0.000441	CcSEcCtD
Nelfinavir—Vomiting—Doxorubicin—urinary bladder cancer	7.79e-05	0.000436	CcSEcCtD
Nelfinavir—Rash—Doxorubicin—urinary bladder cancer	7.73e-05	0.000433	CcSEcCtD
Nelfinavir—Dermatitis—Doxorubicin—urinary bladder cancer	7.72e-05	0.000432	CcSEcCtD
Nelfinavir—Headache—Doxorubicin—urinary bladder cancer	7.68e-05	0.00043	CcSEcCtD
Nelfinavir—Nausea—Doxorubicin—urinary bladder cancer	7.28e-05	0.000408	CcSEcCtD
Nelfinavir—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	2.31e-05	0.00024	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—NQO1—urinary bladder cancer	2.29e-05	0.000238	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.28e-05	0.000237	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—NQO1—urinary bladder cancer	2.27e-05	0.000236	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—RRM2—urinary bladder cancer	2.25e-05	0.000234	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	2.24e-05	0.000233	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	2.22e-05	0.000231	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	2.22e-05	0.000231	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—RRM2—urinary bladder cancer	2.2e-05	0.000229	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.18e-05	0.000227	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	2.18e-05	0.000227	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—TYMP—urinary bladder cancer	2.18e-05	0.000227	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.16e-05	0.000225	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.16e-05	0.000225	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.13e-05	0.000221	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	2.12e-05	0.000221	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	2.12e-05	0.000221	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—NQO1—urinary bladder cancer	2.11e-05	0.00022	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.09e-05	0.000218	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.09e-05	0.000218	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.09e-05	0.000217	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	2.09e-05	0.000217	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	2.08e-05	0.000217	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ENO2—urinary bladder cancer	2.08e-05	0.000217	CbGpPWpGaD
Nelfinavir—SLC22A1—Neuronal System—HRAS—urinary bladder cancer	2.06e-05	0.000215	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—GSTP1—urinary bladder cancer	2.06e-05	0.000215	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.04e-05	0.000212	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ENO2—urinary bladder cancer	2.04e-05	0.000212	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	2.04e-05	0.000212	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	2.02e-05	0.00021	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—TYMP—urinary bladder cancer	2e-05	0.000208	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2e-05	0.000208	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.99e-05	0.000207	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—TYMP—urinary bladder cancer	1.99e-05	0.000207	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.98e-05	0.000206	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	1.98e-05	0.000206	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—NAT2—urinary bladder cancer	1.97e-05	0.000205	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	1.96e-05	0.000204	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.94e-05	0.000202	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.93e-05	0.000201	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—NAT2—urinary bladder cancer	1.92e-05	0.0002	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	1.92e-05	0.0002	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—GSTP1—urinary bladder cancer	1.91e-05	0.000199	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.91e-05	0.000198	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	1.9e-05	0.000197	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	1.9e-05	0.000197	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	1.89e-05	0.000197	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	1.82e-05	0.000189	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—NAT2—urinary bladder cancer	1.81e-05	0.000188	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.8e-05	0.000187	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	1.78e-05	0.000186	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.78e-05	0.000185	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—TYMS—urinary bladder cancer	1.78e-05	0.000185	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—GSTP1—urinary bladder cancer	1.76e-05	0.000183	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—TYMS—urinary bladder cancer	1.76e-05	0.000183	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—NCOR1—urinary bladder cancer	1.76e-05	0.000183	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—GSTM1—urinary bladder cancer	1.76e-05	0.000183	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	1.74e-05	0.000181	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	1.74e-05	0.000181	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.71e-05	0.000178	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.7e-05	0.000177	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—RRM2—urinary bladder cancer	1.7e-05	0.000177	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—TYMP—urinary bladder cancer	1.7e-05	0.000177	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—GPX1—urinary bladder cancer	1.68e-05	0.000175	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.68e-05	0.000175	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—NQO1—urinary bladder cancer	1.68e-05	0.000175	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	1.68e-05	0.000174	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—GPX1—urinary bladder cancer	1.67e-05	0.000173	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.66e-05	0.000173	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—ERCC2—urinary bladder cancer	1.65e-05	0.000172	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—NQO1—urinary bladder cancer	1.64e-05	0.000171	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—TYMS—urinary bladder cancer	1.64e-05	0.00017	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.64e-05	0.00017	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	1.64e-05	0.00017	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.63e-05	0.00017	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—NCOR1—urinary bladder cancer	1.62e-05	0.000169	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—GSTM1—urinary bladder cancer	1.62e-05	0.000169	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	1.59e-05	0.000165	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ENO2—urinary bladder cancer	1.57e-05	0.000164	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	1.57e-05	0.000164	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.57e-05	0.000163	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.56e-05	0.000163	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—MTHFR—urinary bladder cancer	1.55e-05	0.000161	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—GPX1—urinary bladder cancer	1.55e-05	0.000161	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.55e-05	0.000161	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	1.54e-05	0.00016	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.54e-05	0.00016	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.54e-05	0.00016	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—NAT2—urinary bladder cancer	1.54e-05	0.00016	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	1.53e-05	0.000159	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	1.53e-05	0.000159	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—ERCC2—urinary bladder cancer	1.52e-05	0.000158	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.5e-05	0.000156	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.49e-05	0.000155	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.45e-05	0.000151	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.45e-05	0.000151	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.44e-05	0.000149	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.44e-05	0.000149	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—MTHFR—urinary bladder cancer	1.43e-05	0.000149	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.43e-05	0.000148	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.4e-05	0.000146	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	1.4e-05	0.000146	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.4e-05	0.000145	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.39e-05	0.000145	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.37e-05	0.000143	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.37e-05	0.000142	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	1.36e-05	0.000141	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—RRM2—urinary bladder cancer	1.33e-05	0.000138	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.31e-05	0.000136	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	1.31e-05	0.000136	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—TYMS—urinary bladder cancer	1.3e-05	0.000135	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	1.29e-05	0.000134	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	1.29e-05	0.000134	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.27e-05	0.000132	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.27e-05	0.000132	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PPARG—urinary bladder cancer	1.26e-05	0.000131	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.26e-05	0.000131	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.26e-05	0.000131	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	1.25e-05	0.00013	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PPARG—urinary bladder cancer	1.25e-05	0.00013	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.24e-05	0.000129	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—GPX1—urinary bladder cancer	1.23e-05	0.000128	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.23e-05	0.000128	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.23e-05	0.000128	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.23e-05	0.000128	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.22e-05	0.000127	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.21e-05	0.000126	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CREBBP—urinary bladder cancer	1.21e-05	0.000126	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.21e-05	0.000125	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	1.2e-05	0.000125	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.19e-05	0.000124	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.18e-05	0.000123	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.18e-05	0.000123	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.17e-05	0.000122	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.17e-05	0.000121	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PPARG—urinary bladder cancer	1.16e-05	0.000121	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.16e-05	0.00012	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.14e-05	0.000118	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.12e-05	0.000117	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CREBBP—urinary bladder cancer	1.12e-05	0.000116	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.11e-05	0.000116	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	1.09e-05	0.000113	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.07e-05	0.000112	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	1.07e-05	0.000111	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.06e-05	0.00011	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—EP300—urinary bladder cancer	1.04e-05	0.000108	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.03e-05	0.000107	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.02e-05	0.000107	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.02e-05	0.000106	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PTGS2—urinary bladder cancer	9.9e-06	0.000103	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—NQO1—urinary bladder cancer	9.89e-06	0.000103	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—TYMS—urinary bladder cancer	9.84e-06	0.000102	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	9.82e-06	0.000102	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.79e-06	0.000102	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	9.74e-06	0.000101	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	9.73e-06	0.000101	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	9.73e-06	0.000101	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	9.65e-06	0.0001	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—TYMS—urinary bladder cancer	9.61e-06	9.99e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	9.6e-06	9.98e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GSTM1—urinary bladder cancer	9.5e-06	9.88e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—NCOR1—urinary bladder cancer	9.5e-06	9.88e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ENO2—urinary bladder cancer	9.47e-06	9.85e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	9.47e-06	9.85e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.34e-06	9.72e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	9.33e-06	9.7e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GPX1—urinary bladder cancer	9.32e-06	9.69e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PPARG—urinary bladder cancer	9.23e-06	9.6e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	9.19e-06	9.55e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	9.15e-06	9.51e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PTGS2—urinary bladder cancer	9.13e-06	9.5e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GPX1—urinary bladder cancer	9.09e-06	9.46e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—TYMS—urinary bladder cancer	9.05e-06	9.42e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PPARG—urinary bladder cancer	9.02e-06	9.38e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—TYMS—urinary bladder cancer	8.98e-06	9.34e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	8.95e-06	9.31e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	8.95e-06	9.31e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ERCC2—urinary bladder cancer	8.93e-06	9.29e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—EP300—urinary bladder cancer	8.89e-06	9.25e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	8.87e-06	9.23e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	8.87e-06	9.23e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	8.86e-06	9.22e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	8.66e-06	9.01e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PTEN—urinary bladder cancer	8.64e-06	8.98e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	8.6e-06	8.94e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GPX1—urinary bladder cancer	8.57e-06	8.91e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PTEN—urinary bladder cancer	8.56e-06	8.9e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GPX1—urinary bladder cancer	8.5e-06	8.84e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	8.41e-06	8.75e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—MTHFR—urinary bladder cancer	8.39e-06	8.73e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.37e-06	8.71e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	8.34e-06	8.68e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	8.25e-06	8.58e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—EP300—urinary bladder cancer	8.24e-06	8.57e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—EP300—urinary bladder cancer	8.16e-06	8.49e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.98e-06	8.3e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PTEN—urinary bladder cancer	7.97e-06	8.29e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	7.91e-06	8.23e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	7.84e-06	8.16e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—TYMS—urinary bladder cancer	7.67e-06	7.98e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NQO1—urinary bladder cancer	7.63e-06	7.94e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—EP300—urinary bladder cancer	7.6e-06	7.9e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	7.58e-06	7.89e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	7.58e-06	7.89e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GPX1—urinary bladder cancer	7.26e-06	7.55e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	7.26e-06	7.55e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	7.13e-06	7.41e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	7.1e-06	7.38e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PPARG—urinary bladder cancer	6.97e-06	7.25e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PPARG—urinary bladder cancer	6.81e-06	7.08e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	6.7e-06	6.97e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	6.7e-06	6.97e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CREBBP—urinary bladder cancer	6.54e-06	6.8e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PPARG—urinary bladder cancer	6.41e-06	6.67e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	6.37e-06	6.62e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PPARG—urinary bladder cancer	6.36e-06	6.61e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PTEN—urinary bladder cancer	6.33e-06	6.58e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PTEN—urinary bladder cancer	6.19e-06	6.44e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	6.16e-06	6.41e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	6.11e-06	6.35e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—EP300—urinary bladder cancer	6.04e-06	6.28e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—TYMS—urinary bladder cancer	5.92e-06	6.16e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—EP300—urinary bladder cancer	5.9e-06	6.14e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	5.85e-06	6.09e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	5.85e-06	6.09e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GPX1—urinary bladder cancer	5.6e-06	5.83e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	5.5e-06	5.72e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	5.49e-06	5.71e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PPARG—urinary bladder cancer	5.43e-06	5.65e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PTGS2—urinary bladder cancer	5.35e-06	5.57e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	5.22e-06	5.43e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	5.17e-06	5.38e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	5.05e-06	5.25e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	5e-06	5.2e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PTEN—urinary bladder cancer	4.78e-06	4.98e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PTEN—urinary bladder cancer	4.67e-06	4.86e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—EP300—urinary bladder cancer	4.56e-06	4.75e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—EP300—urinary bladder cancer	4.45e-06	4.63e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PTEN—urinary bladder cancer	4.4e-06	4.58e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PTEN—urinary bladder cancer	4.36e-06	4.54e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	4.27e-06	4.45e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—EP300—urinary bladder cancer	4.2e-06	4.36e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PPARG—urinary bladder cancer	4.19e-06	4.36e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—EP300—urinary bladder cancer	4.16e-06	4.33e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4.03e-06	4.19e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PTEN—urinary bladder cancer	3.73e-06	3.88e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—EP300—urinary bladder cancer	3.55e-06	3.7e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.3e-06	3.43e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.88e-06	2.99e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.74e-06	2.85e-05	CbGpPWpGaD
